Marshall Wace

Marshall Wace’s Ocular Therapeutix OCUL Stock Holding History

Marshall Wace’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.27M	Sell	740,803 -636,400	-46%	-$6.07M	0.01%	1193
2025 Q4	$16.7M	Sell	1,377,203 -224,246	-14%	-$2.72M	0.02%	692
2025 Q3	$18.7M	Buy	+1,601,449	New	+$19.1M	0.02%	680
2024 Q4	–	Sell	-87,743	Closed	-$763K	–	2906
2024 Q3	$763K	Sell	87,743 -341,849	-80%	-$2.82M	﹤0.01%	1765
2024 Q2	$2.94M	Buy	+429,592	New	+$2.65M	﹤0.01%	1204
2023 Q3	–	Sell	-15,149	Closed	-$78.2K	–	2582
2023 Q2	$78.2K	Buy	+15,149	New	+$90.1K	﹤0.01%	2348
2022 Q4	–	Sell	-531,636	Closed	-$2.21M	–	3335
2022 Q3	$2.21M	Buy	+531,636	New	+$2.68M	0.01%	1941
2021 Q4	–	Sell	-89,335	Closed	-$893K	–	4230
2021 Q3	$893K	Buy	89,335 +76,221	+581%	+$856K	﹤0.01%	2088
2021 Q2	$186K	Buy	+13,114	New	+$199K	﹤0.01%	2461
2020 Q2	–	Sell	-32,533	Closed	-$161K	–	1842
2020 Q1	$161K	Buy	+32,533	New	+$161K	﹤0.01%	1222

Other funds holding OCUL

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return